Krishnaswamy Yeleswaram

Chief Development Officer, Rapport Therapeutics, Inc.

Bought, 12 months

$0.0M

Sold, 12 months

$4.5M

Companies

Latest trade

Aug 25, 2026

Companies

Rapport Therapeutics, Inc.Chief Development Officer −$4.5M

Trades

RAPP Sold 37,000 shares at $50.64 · planned $1.9M Aug 25

RAPP Sold 13,160 shares at $50.00 · planned $0.7M Aug 24

RAPP Sold 404 shares at $49.90 · planned $0.0M Aug 19

RAPP Sold 20,225 shares at $39.99 · planned $0.8M Apr 17

RAPP Sold 10,200 shares at $35.08 · planned $0.4M Apr 14

RAPP Sold 9,165 shares at $34.97 · planned $0.3M Apr 13

RAPP Sold 500 shares at $34.98 · planned $0.0M Apr 10

RAPP Sold 360 shares at $34.90 · planned $0.0M Apr 8

RAPP Sold 10,115 shares at $29.99 · planned $0.3M Mar 25

RAPP Sold 2,840 shares at $30.05 $0.1M Dec 31

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.